BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30880319)

  • 1. Synergistic anti-candida activities of lactoferrin and the lactoperoxidase system.
    Nakano M; Suzuki M; Wakabayashi H; Hayama K; Yamauchi K; Abe F; Abe S
    Drug Discov Ther; 2019; 13(1):28-33. PubMed ID: 30880319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds.
    Wakabayashi H; Okutomi T; Abe S; Hayasawa H; Tomita M; Yamaguchi H
    Adv Exp Med Biol; 1998; 443():229-37. PubMed ID: 9781363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis.
    Venkatesh MP; Rong L
    J Med Microbiol; 2008 Sep; 57(Pt 9):1113-1121. PubMed ID: 18719181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategy by lactoperoxidase and lactoferrin combination: Immunomodulatory and antibacterial activity against multidrug-resistant Acinetobacter baumannii.
    Mahdi L; Mahdi N; Al-Kakei S; Musafer H; Al-Joofy I; Essa R; Zwain L; Salman I; Mater H; Al-Alak S; Al-Oqaili R
    Microb Pathog; 2018 Jan; 114():147-152. PubMed ID: 29155126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents.
    Wakabayashi H; Abe S; Okutomi T; Tansho S; Kawase K; Yamaguchi H
    Microbiol Immunol; 1996; 40(11):821-5. PubMed ID: 8985937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans.
    Wakabayashi H; Takakura N; Teraguchi S; Tamura Y
    Microbiol Immunol; 2003; 47(1):37-43. PubMed ID: 12636251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans.
    Samaranayake YH; Samaranayake LP; Wu PC; So M
    APMIS; 1997 Nov; 105(11):875-83. PubMed ID: 9393559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of novel nanocombinations of bovine milk proteins (lactoperoxidase and lactoferrin) for combating different human cancer cell lines.
    Abu-Serie MM; El-Fakharany EM
    Sci Rep; 2017 Dec; 7(1):16769. PubMed ID: 29196676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model.
    Takakura N; Wakabayashi H; Ishibashi H; Yamauchi K; Teraguchi S; Tamura Y; Yamaguchi H; Abe S
    J Med Microbiol; 2004 Jun; 53(Pt 6):495-500. PubMed ID: 15150327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils.
    Ueta E; Tanida T; Osaki T
    J Pept Res; 2001 Mar; 57(3):240-9. PubMed ID: 11298926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of orally administered bovine lactoferrin and lactoperoxidase on influenza virus infection in mice.
    Shin K; Wakabayashi H; Yamauchi K; Teraguchi S; Tamura Y; Kurokawa M; Shiraki K
    J Med Microbiol; 2005 Aug; 54(Pt 8):717-723. PubMed ID: 16014423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
    Kobayashi T; Kakeya H; Miyazaki T; Izumikawa K; Yanagihara K; Ohno H; Yamamoto Y; Tashiro T; Kohno S
    Jpn J Infect Dis; 2011; 64(4):292-6. PubMed ID: 21788703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined inhibitory effect of lactoferrin and lactoperoxidase system on the viability of Streptococcus mutans, serotype c.
    Soukka T; Lumikari M; Tenovuo J
    Scand J Dent Res; 1991 Oct; 99(5):390-6. PubMed ID: 1754841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between hyaluronic acid, lysozyme, and the glucose oxidase-mediated lactoperoxidase system in enzymatic and candidacidal activities.
    Cho MA; Kim YY; Chang JY; Kho HS
    Arch Oral Biol; 2013 Oct; 58(10):1349-56. PubMed ID: 23845750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of Growth of Candida albicans by a Lysozyme-chitosan Conjugate, LYZOX and its Combination with Decanoic Acid].
    Kageshima H; Hayama K; Takahashi M; Abe M; Yamada T; Saito A; Hirano S; Murakami Y; Abe S
    Med Mycol J; 2017; 58(3):J63-J69. PubMed ID: 28855481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of inhibitory activity on mycelial growth of Candida albicans and therapy for murine oral candidiasis by the combined use of terpinen-4-ol and a middle-chain fatty acid, capric acid].
    Ninomiya K; Hayama K; Ishijima S; Takahashi M; Kurihara J; Abe S
    Yakugaku Zasshi; 2013; 133(1):133-40. PubMed ID: 23292030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral lactoferrin protects against experimental candidiasis in mice.
    Velliyagounder K; Alsaedi W; Alabdulmohsen W; Markowitz K; Fine DH
    J Appl Microbiol; 2015 Jan; 118(1):212-21. PubMed ID: 25319508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented inhibition of growth of Candida albicans by neutrophils in the presence of lactoferrin.
    Okutomi T; Abe S; Tansho S; Wakabayashi H; Kawase K; Yamaguchi H
    FEMS Immunol Med Microbiol; 1997 Jun; 18(2):105-12. PubMed ID: 9223614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungicidal effect of human lactoferrin against Candida albicans.
    Soukka T; Tenovuo J; Lenander-Lumikari M
    FEMS Microbiol Lett; 1992 Jan; 69(3):223-8. PubMed ID: 1555756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor.
    Tanida T; Rao F; Hamada T; Ueta E; Osaki T
    Infect Immun; 2001 Jun; 69(6):3883-90. PubMed ID: 11349055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.